Showing results (141-150 of 179) with videos related to

Sort By:
Pageof 18
Biochimica Et Biophysica Acta. Molecular and Cell Biology of Lipids|November 23, 2021
Abdominal obesity negatively influences key metrics of reverse cholesterol transportJennifer Härdfeldt, Marica Cariello, Sara Simonelli, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 20, 2020
Dimethyl fumarate ameliorates hepatic inflammation in alcohol related liver diseaseMoris Sangineto, Felix Grabherr, Timon E Adolph, et al.
Free Radical Biology & Medicine|March 31, 2007
Parallel intestinal and liver injury during early cholestasis in the rat: modulation by bile salts and antioxidantsPiero Portincasa, Ignazio Grattagliano, Mario Testini, et al.
Hepatology Communications|July 29, 2022
Reduction in gut-derived MUFAs via intestinal stearoyl-CoA desaturase 1 deletion drives susceptibility to NAFLD and hepatocarcinomaSimon Ducheix, Elena Piccinin, Claudia Peres, et al.
Frontiers in Nutrition|November 17, 2022
Extra virgin olive oil extract rich in secoiridoids induces an anti-inflammatory profile in peripheral blood mononuclear cells from obese childrenStefania De Santis, Pasquale Crupi, Laura Piacente, et al.
Circulation|November 24, 2017
Pericardial Adipose Tissue Regulates Granulopoiesis, Fibrosis, and Cardiac Function After Myocardial InfarctionMichael Horckmans, Mariaelvy Bianchini, Donato Santovito, et al.
Plos One|May 5, 2012
The insulin receptor substrate 1 (IRS1) in intestinal epithelial differentiation and in colorectal cancerDiana L Esposito, Federica Aru, Rossano Lattanzio, et al.
Gut Microbes|July 5, 2022
Recovery of Bacteroides thetaiotaomicron ameliorates hepatic steatosis in experimental alcohol-related liver diseaseMoris Sangineto, Christoph Grander, Felix Grabherr, et al.
Molecular Therapy. Nucleic Acids|July 10, 2025
Hepatocyte delivery of miR-34b/c reduces hepatic stellate cell activation and improves liver fibrosisPasquale Piccolo, Rosa Ferriero, Claudia Perna, et al.
Ebiomedicine|April 8, 2020
Fibroblast Growth Factor 19 modulates intestinal microbiota and inflammation in presence of Farnesoid X ReceptorRaffaella Maria Gadaleta, Oihane Garcia-Irigoyen, Marica Cariello, et al.
Pageof 18